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A reciprocal relationship exists between the cytochrome P-450 content and 8-amino-
laevulinate synthetase activity in adult rats. In young rats the basal 8-aminolaevulinate
synthetase activity is higher and the cytochrome P-450 content is lower compared with
the adult rat liver. Administration of allylisopropylacetamide neither induces the enzyme
nor causes degradation of cytochrome P-450 in the young rat liver, unlike adult rat liver.
Allylisopropylacetamide fails to induce 8-aminolaevulinate synthetase in adrenalectom-
ized-ovariectomized animals or intact animals pretreated with successive doses ofthe drug,
in the absence of cortisol. The cortisol-mediated induction of the enzyme is sensitive to
actinomycin D. Allylisopropylacetamide administration degrades microsomal haem but
not nuclear haem. Haem does not counteract the decrease in cytochrome P-450 content
caused by allylisopropylacetamide administration, but there is evidence for the formation
of drug-resistant protein-bound haem in liver microsomal material under these condi-
tions. Phenobarbital induces 8-aminolaevulinate synthetase under conditions when there
is no breakdown of cytochrome P450. On the basis of these results and those already
published, a model is proposed for the regulation of 8-aminolaevulinate synthetase
induction in rat liver.
8-Aminolaevulinate synthetase, the first and rate-
limiting enzyme of the haem biosynthetic pathway, is
induced in the animal liver by a wide variety offoreign
chemicals and physiological steroid metabolites.
Haem, the end-product of the pathway, represses the
induction of the enzyme (Granick, 1966; Waxman
et al., 1966; Marver et al., 1966). Granick (1966)
proposed that haem functions as the co-repressor,
controlling 8-aminolaevulinate synthetase induction
by combining with the apo-repressor and forming
the functional repressor. He suggested that drugs and
steroids compete withhaem, preventing the formation
of the functional repressor, and thereby cause enzyme
de-repression. However, a wide variety of chemicals
with divergent structures are able to induce 8-amino-
laevulinate synthetase and it is difficult to visualize
how all these chemicals could compete with or prevent
haem binding to the apo-repressor. Burnham (1969)
therefore suggested that all these foreign chemicals
facilitate the accumulation of a common metabolite
'X' that competes with haem. Because some of the
physiological steroid metabolites are potent inducers
of 8-aminolaevulinate synthetase in the chick embryo
liver culture system (Granick & Kappas, 1967;
Kappas & Granick, 1968), Burnham (1969) suggested
that 'X' could as well be a steroid metabolite. Subse-
quent studies by Sassa & Granick (1970) with the
chick embryo liver culture system have indicated that
the porphyrinogenic agent, allylisopropylacetamide,
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a potent inducer of 8-aminolaevulinate synthetase,
as well as haem, the 'co-repressor', probably act at the
translational level. Studies by Strand et al. (1972)
with the chick embryo culture system have supported
this contention.
Recent investigations have shown that a primary
effect ofallylisopropylacetamide is to cause a decrease
in liver cytochromeP 450 content (De Matteis, 1970;
Meyer & Marver, 1971). Cytochrome P-450 plays a
key role in microsomal electron transport, mediating
drug metabolism through the mixed-function oxidase
system. The decrease in cytochrome P450 contents
caused by allylisopropylacetamide administration
involves the degradation of the haem moiety (De
Matteis, 1970; Meyer & Marver, 1971). It has been
suggested that this primary action of allylisopropyl-
acetamide in causing the destruction of cytochrome
P450 haem might be connected with the induction of
8-aminolaevulinate synthetase, haem being the 'co-
repressor' for the enzyme (De Matteis, 1970; Meyer
& Marver, 1971; Landaw et al., 1970). Satyana-
rayana Rao et al. (1972) examined the inter-relation-
ship between cytochrome P450 degradation and
8-aminolaevulinate synthetase induction and sug-
gested that haem degradation is one of the conditions
necessary for the enzyme to be induced by allyliso-
propylacetamide. In the present report we propose,
on the basis of additional experiments as well as pub-
lished results, that the apo-protein of a microsomal
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haemoprotein, which could be a species of apo-
cytochrome P-450 or a closely associated protein
undergoing a similar metabolic fate, facilitates induc-
tion of 8-aminolaevulinate synthetase at the trans-
lational level. Haem binding to this apo-protein
abolishes this positive control. The translation of
&-aminolaevulinate synthetase mRNA provides a
trigger for transcription and formation of more
mRNA. A hormone metabolite is required for the
transcription process.
Experimental
Animals
Female rats (100-1 I0g) as well as male rats (120-
130g) ofthe local Institute strain were used; 5-day-old
rats were used in some experiments. The concentra-
tions ofthe compounds injected aregiven in the respec-
tive tables and figures as well as in the accompanying
paper (Satyanarayana Rao & Padmanaban, 1973).
Hormone involvement in 8-aminolaevulinate
synthetase induction was studied in adrenalectom-
ized-ovariectomized rats. The animals were main-
tained on stock diet and saline for 5 days before use.
For the first 24h after the operation the animals were
also given glucose.
Methods
Determination of cytochrome P-450 content and
&-aminolaevulinate synthetase activity. Cytochrome
P-450 was estimated in liver microsomal suspensions
by the method of Omura & Sato (1964).
8-Aminolaevulinate synthetase activity was assayed
in liver homogenate, mitochondria and postmicro-
somal supernatant as described by Hayashi et al.
(1969). For this purpose, the livers were homogenized
with 0.25M-sucrose inTKM buffer (0.05 M-Tris-HCI,
pH 7.5, 0.025M-KCI and 0.005M-MgC12) containing
0.1mM-pyridoxal phosphate (4ml/g of liver) in a
Potter-Elvehjem homogenizer. After removing the
800g sediment, the supernatant was spun at 100OOg
for 15min and the sediment, after washing, was used
as the mitochondrial fraction. The postmitochondrial
supernatant was spun at 105OOOg for 60 min and the
supernatant was used as the soluble fraction. The
homogenate incubation mixture in a total volume of
2ml contained: 1.0ml of homogenate, 200utmol of
glycine, 20,umol of EDTA and 150lmol of Tris-
HCI buffer, pH7.4. The enzyme was assayed in the
mitochondrial and soluble fractions by using a suc-
cinyl-CoA-generating system in a total volume of
2ml that contained: 0.5ml of mitochondrial suspen-
sion or supernatant, 200,umol of glycine, 20,umol of
succinate, 20,tmol of ATP, 0.3,umol of pyridoxal
phosphate, 0.3 ,umol of CoA, 10,tmol of MgCl2,
0.8[zmol of EDTA, 120tmol of Tris-HCl buffer,
pH7.5, and succinyl-CoA synthetase, catalysing the
formation of 10,mol of succinyl-CoA/h. The assay
mixtures were incubated for 1 h at 37°C and the re-
action was stopped with 1 ml of 12.5% (w/v) trichloro-
acetic acid. Aminolaevulinate was determined in the
protein-free supernatant by using acetylacetone and
column fractionation as described by Hayashi et al.
(1969) with slight modifications.
Degradation of microsomal and nuclear haem.
Female rats were injected with amino[4-'4C]laevulin-
ate (3,Ci/animal) intraperitoneally. At 6h after the
tracer administration, the animals were injected with
allylisopropylacetamide (300mg/kg) subcutaneously.
The animals were then killed at different times after
allylisopropylacetamide administration and the livers
were processed for the isolation ofhaem from micro-
somal material and nuclei. Nuclei were isolated from
liver homogenates by the method of Blobel & Potter
(1966). Homogenate (7ml in 0.25M-sucrose-TKM
buffer) was mixed with 14ml of 2.3 M-sucrose inTKM
buffer and layered over 8 ml of 2.3 M-sucrose in TKM
buffer. Centrifugation was carried out by using a
Beckman SW 25 rotor for 120min at 24000rev./min.
The nuclear pellet was resuspended in 32ml of 2.3M-
sucrose in TKM buffer and the run was repeated.
The pellet was finally suspended in 0.25M-sucrose in
TKM buffer and centrifuged at 800g for 10min. The
pellet was washed three times by the same procedure.
For the isolation of microsomal material (subse-
quently termed 'microsomes'), a portion of the
0.25 M-sucrose homogenate was centrifuged at
25000g for 10min and the supernatant was diluted
with 1.15% (w/v) KCI and then centrifuged at
105 OOOg for 90min. The pellet was rinsed with KCl
and finally suspended in potassium phosphate buffer
(0.05M, pH 7.5).
Haem was isolated from the microsomal and nuc-
lear suspensions after washing the pellets with organic
solvents to remove lipids. Haem was split by using
ethyl acetate-acetic acid (3:1, v/v) and the ethyl ace-
tate layer was freed of porphyrins and other possible
degradation products of haem. Portions of the ethyl
acetate layer were transferred to vials, evaporated to
dryness under vacuum and then counted for radio-
activity. This method ofhaem isolation and the radio-
active purity of the final product have been standard-
ized and described by Levin et al. (1972). Direct
determination of the protohaem content in the micro-
somal suspensions revealed that the recovery of the
haem in the final preparation is consistently around
70t2%.
[59Fe]Ferric citrate incorporation into microsomal
haem. [59Fe]Ferric citrate (5pCi/animal) was injected
intraperitoneally into female rats and allylisopropyl-
acetamide was injected subcutaneously. After 4h
the animals were killed and the livers were processed
for the isolation of microsomal haem as described
above except that 1.15% (w/v) KCI was used for
homogenization.
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Protein detennination was carried out in homo-
genate and microsomal suspensions by the method
of Lowry et al. (1951) with bovine serum albumin as
standard. The suspensions were diluted suitably so as
to contain a final concentration of 1 % (w/v) deoxy-
cholate.
Radioactivity measurements. 14C radioactivity
measurements were made in a liquid-scintillation
counter (Beckman LS-100) by using 0.5% of 2,5-
diphenyloxazole in toluene as the scintillation fluid.
Quench corrections were applied by the channels-
ratio method. s9Fe radioactivity measurements were
made in a well-type scintillation counter attached to a
decade scaler (Nuclear-Chicago).
Results
There is a reciprocal relationship between the con-
tent of cytochrome P-450 and the extent of induction
of 8-aminolaevulinate synthetase in rat liver (De
Matteis, 1970; Meyer & Marver, 1971; Satyana-
rayana Rao et al., 1972). The results in Table 1 indi-
cate another situation where this relationship holds.
In young rats the basal hepatic &-aminolaevulinate
synthetase activity is higher than that in adult rats,
and the reverse is seen with cytochromeP-450 content.
Allylisopropylacetamide fails to induce 8-amino-
laevulinate synthetase in young rats and neither is
there a fall in cytochrome P-450 content. The refrac-
tory nature of young rats to 8-aminolaevulinate syn-
thetase induction has also been reported by Song
et al. (1971). The marginal effects of allylisopropyl-
acetamide could be due to the low ability of the
young rat liver to metabolize the drug. In young rats
the drug-metabolizing enzyme activities are low (Song
et al., 1971) and allylisopropylacetamide has to be
metabolized before it can lead to degradation of cyto-
chrome P-450 (De Matteis, 1971).
The results in Table 2 indicate that in adrenalectom-
ized-ovariectomized rats allylisopropylacetamide
leads to cytochrome P450 breakdown, but 8-amino-
laevulinate synthetase is not induced. However,
administration of cortisol with the drug results in
induction of the enzyme without in any way altering
the breakdown of cytochrome P-450. The effect of
cortisol on enzyme induction is blocked by actino-
mycin D. The results in Table 3 indicate that cortisol
is again required for the induction of8-aminolaevulin-
ate synthetase by allylisopropylacetamide when the
animal has received repeated administrations of the
drug. It has previously been shown (De Matteis,
1971) that the initial decrease in cytochrome
P-450 content after allylisopropylacetamide ad-
ministration is a - temporary phenomenon and
this is followed by a regeneration phase when more
than normal amounts of cytochrome P-450 are
reached 24h after the drug administration. The
results in Table 3 indicate that each administration
of allylisopropylacetamide at 24h intervals causes a
fresh decrease in cytochrome P-450 content, but
8-aminolaevulinate synthetase is poorly induced
after the fifth administration of the drug unless cor-
tisol is also injected simultaneously. The cortisol-
mediated effect is blocked by actinomycin D.
The actinomycin D sensitivity of the cortisol-
mediated effect indicates that possibly the hormone
metabolite acts at the transcriptional level. Haematin
has been reported to act at the translational level in
the chick embryo liver culture system (Sassa &
Granick, 1970; Strand et al., 1972). To further resolve
this question, the fate of labelled nuclear and micro-
somal haem was investigated after allylisopropyl-
acetamide administration. The results in Fig. 1
show that, whereas allylisopropylacetamide causes
loss of radioactivity from microsomal haem, the
nuclear haem radioactivity remains constant. Nuclear
membranes have been reported to contain haemo-
proteins. The contribution of the endoplasmic
reticulum to the nuclear membranes in this regard
has been recognized, although it is thought that
Table 1. Effect of allylisopropylacetamide on 8-aminolaevulinate synthetase induction and cytochrome P-450
content in young rats
Rats (5 days old; 7-8g) as well as fed adult female rats (100-1lOg) were injected with allylisopropylacetamide
(400mg/kg body wt.) subcutaneously. The animals were killed after 4h and the livers were processed for the assay
of 8-aminolaevulinate synthetase activity and cytochromeP450 content. The results represent the average of two
experiments in which five livers of young rats and two livers of adult rats were pooled in each experiment.
Treatment
Saline control
Allylisopropylacetamide
Saline control
AllIlisooronvlacetamide
8-Aminolaevulinate
synthetase activity
(nmol of aminolaevulinate/g
of liver)
32.2
35.8
15.3
90.0
Cytochrome P-450 content
(nmol/mg of microsomal
protein)
0.38
0.37
0.77
0.59
Animal used
Young rat
Young rat
Adult rat
Adult rat
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Table 3. Effects of cortisol on allylisopropylacetamide-mediated induction of 8-aminolaevulinate synthetase and
destruction ofcytochrome P-450 in continuously drug-treated rats
Fed female rats (100-1 O0g) were given subcutaneous injections of allylisopropylacetamide (400mg/kg body wt.)
every 24h. Cortisol (0mg/animal) and actinomycinD (0.15mg/animal) were injected intraperitoneally into rats
along with the first or fifth injection ofallylisopropylacetamide. The animals were killed 5h after the last drug injec-
tion and the livers were processed for 8-aminolaevulinate synthetase assay and cytochrome P-450 contents. The
results represent the means ±s.. obtained from three experiments in which two livers were pooled in each
experiment.
Treatment
Normal
Allylisopropylacetamide (one
injection)
Allylisopropylacetamide (two
injections)
Allylisopropylacetamide (one
injection) +cortisol
Allylisopropylacetamide (five
injections)
Allylisopropylacetamide (five
injections) +cortisol
Allylisopropylacetamide (five
injections)+cortisol+actino-
mycin D
Cortisol
8-Aminolaevulinate synthetase activity
(nmol of aminolaevulinate/g of liver)
15.3 ± 1.2
89.6± 3.4
140.6± 2.9
72.4± 2.6
25.2±2.4
58.9± 1.2
22.3 ± 122
18.2±3.6
Cytochrome P-450 content
(nmol/mg ofmicrosomal protein)
0.76±0.03
0.61 ± 0.02
0.59±0.03
0.62 ± 0.01
0.58±0.04
0.56 ± 0.03
0.61 ± 0.03
0.78±0.02
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Fig. 1. Effect of allylisopropylacetamide injection on
the loss of radioactivity from microsomal and nuclear
haem
The experimental details are given in the text. The
radioactivity results in the figure are the actual counts
recorded in a typical experiment and correspond to
the haem isolated from 15mg of nuclear protein and
50mg of microsomal protein. *, Microsomal haem
radioactivity; A, nuclear haem radioactivity.
cytochrome P-450 is not present in purified nuclear
membrane preparations (Kasper, 1971; Berezney
& Crane, 1971). In the present study purified whole
nuclear preparations were used. Although contri-
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bution of haem radioactivity by the microsomal
membrane fragments to the nuclear haem radio-
activity is not ruled out, the fact that the bulk of nu-
clear haem radioactivity remains constant when the
microsomal haem radioactivity decreases significantly
owing to allylisopropylacetamide administration
indicates that the contamination is not sufficiently
significant to vitiate the results. We could not detect
cytochrome P-450 in the whole nuclear preparations.
The effect of haematin on cortisol-mediated induc-
tion of 8-aminolaevulinate synthetase by allyliso-
propylacetamide was studied in adrenalectomized-
ovariectomized rats, to understand the level of inter-
action of these two regulators. The results in Fig. 2
indicate that haematin blocks the enzyme induction
when given with allylisopropylacetamide and cortisol
in adrenalectomized-ovariectomized rats. When
haematin was given 4h after enzyme induction it was
still effective and caused a significant decrease in the
8-aminolaevulinate synthetase activities of the homo-
genate and mitochondria. The soluble enzyme acti-
vity increased slightly initially but subsequently de-
creased. Similar results were obtained when the effect
of haematin on enzyme induction by allylisopropyl-
acetamide was studied in intact animals (Fig. 2).
These results are quantitatively different from those
reported by Hayashi et al. (1972). They reported that
haematin, when given after the enzyme has been
A
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Fig. 2. Effect ofsimultaneous and delayed administration ofhaem on the induction of8-aminolaevulinate synthetase
by allylisopropylacetamide
Female rats were starved for 24h and allylisopropylacetamide was given at a concentration of 300mg/kg body wt.
(a) Induction pattern in the homogenate; (b) induction pattern in mitochondria; (c) induction pattern in cytosol.
*, Normal animals treated with allylisopropylacetamide; o, normal animals treated with allylisopropylacetamide
+haem (at zero time); *, adrenalectomized-ovariectomized animals treated with allylisopropylacetamide+
cortisol (at zero time); o, adrenalectomized-ovariectomized animals treated with allylisopropylacetamide+
cortisol+haemin (at zero time). The arrow indicates the time at which haemin was injected after the induction of
the enzyme. The dashed lines represent the activity of 8-aminolaevulinate synthetase when haemin was
administered 4h after enzyme induction.
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Fig. 3. Effect ofphenobarbital on 8-aminolaevulinate
synthetase activity and cytochrome P-450 content in
starved male rats
Male rats (120-130g) were starved for 24h and
phenobarbital was administered at a concentration
of 80mg/kg body wt. *, 8-Aminolaevulinate synthe-
tase activity in phenobarbital-treated rats; o, 8-
aminolaevulinate synthetase activity in phenobarbital
+actinomycin D-treated rats; *, cytochrome P-450
content in phenobarbital-treated rats; A, cytochrome
P-450 content in phenobarbital+actinomycin D-
treated rats.
induced, failed to suppress homogenate enzyme acti-
vity significantly. They also reported a striking de-
crease in mitochondrial enzyme activity that was
compensated for by a corresponding increase in the
cytosol enzyme activity. In the present study, the
homogenate 8-aminolaevulinate synthetase activity
was found to decrease significantly. The mito-
chondrial enzyme activity decreased significantly, but
the increase in cytosolic enzyme activity was marginal
and transient. The quantitative differences observed
could be due to the concentration of the drug and
haematin employed in the different studies. Strand
et al. (1972) and Sassa & Granick (1970) found a signi-
ficant decrease in homogenate enzyme activity with
the chick embryo liver culture system even when
haematin was administered after the enzyme had
been induced.
The obligatory requirement for cytochrome P-450
breakdown to induce 8-aminolaevulinate synthetase
has been examined with respect to another inducer,
phenobarbital. The results in Fig. 3 indicate that
phenobarbital induces the enzyme to about 2.5-fold
in starved male rats. The enzyme activity reaches
a maximum in about 6-8h. There is no evidence
for any decrease in cytochrome P-450 content. A
detectable increase in cytochrome P-450 content
is seen at lOh after phenobarbital administration.
The increases in a-aminolaevulinate synthetase
activity and cytochrome P-450 content owing to
1973
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phenobarbital administration are sensitive to actino-
mycin D. Similar results have been reported by
Baron & Tephly (1970), except that they observed
very high amounts of enzyme induction by pheno-
barbital. However, in most studies phenobarbital was
found to be a weak or moderate inducer of 8-amino-
laevulinate synthetase in female as well as starved
male rats (Marver et al., 1968; Marver, 1969;
Meyer & Marver, 1971; Satyanarayana Rao et al.,
1972).
Discussion
Evidence for the involvement of cytochrome P.450
degradation in 8-aminolaevulinate synthetase induction
The ability of allylisopropylacetamide to cause a
decrease in cytochrome P.450 content involving the
degradation of the haem moiety, the 'co-repressor' of
8-aminolaevulinate synthetase, has already been
mentioned. In addition, a reciprocal relationship
exists between the changes in the content of cyto-
chrome P-450 and 8-aminolaevulinate synthetase
activity after allylisopropylacetamide administration
(De Matteis, 1970; Meyer & Marver, 1971; Satyana-
rayana Rao et al., 1972). We have shown (Satyana-
rayana Rao et al., 1972) that when the degradation of
cytochrome P.450 owing to allylisopropylacetamide
is prevented by the simultaneous administration of
SKF 525A (Smith, Kline and French Co., Phila-
delphia, Pa., U.S.A.), there is very little induction of
the enzyme. Although the degradation ofcytochrome
P-450 could lead to 8-aminolaevulinate synthetase
induction, we have ruled out the reverse situation,
namely the possibility that the induction of the en-
zyme could cause overproduction of haem, which in
turn might catalyse its own breakdown by the induc-
tion of haem oxygenase (Satynarayana Rao et al.,
1972). In addition, the results obtained with young
rats in the present investigation clearly substantiate
the involvement of cytochrome P-450 degradation in
8-aminolaevulinate synthetase induction.
Evidencefor the participation ofa hormone metabolite
in 8-aminolaevulinate synthetase induction
Granick & Kappas (1967) and Kappas & Granick
(1968) have shown that certain physiological
steroid metabolites are potent inducers of 8-amino-
laevulinate synthetase in the chick embryo liver
culture system. Matsuoka et al. (1968) have shown
that in the intact rat, cortisol has a permissive effect
on the induction of the enzyme. In adrenalectomized
animals they have shown that the enzyme is not in-
duced by allylisopropylacetamide unless the animal
is pretreated with cortisol. The present experiments
with adrenalectomized-ovariectomized rats, as well
as with animals receiving successive doses of the
inducer, indicate that the enzyme is not induced by
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allylisopropylacetamide in the absence of cortisol
administration. However, cortisol has no effect on
the drug-mediated breakdown of cytochrome P-
450. These results indicate that cytochrome P-450
breakdown, as well as the availability of a hormone
metabolite, are necessary requirements for enzyme
induction. These results substantiate our suggestion
(Satyanarayana Rao et al., 1972) that the decreased
ability of allylisopropylacetamide to induce 8-
aminolaevulinate synthetase after repeated admini-
strations of the drug may be caused by the unavail-
ability of the active hormone metabolite owing to
its increased metabolism.
Site ofaction ofhaem, allylisopropylacetamide and the
hormone metabolite
Although Granick (1966) originally proposed that
haem and the drug act at the transcriptional level,
Sassa & Granick (1970) favoured the translational
site ofaction in the chick embryo liver culture system.
Strand et al. (1972) obtained results supporting this
contention by using the same experimental set-up.
The present results indicate that in rat liver allyliso-
propylacetamide-mediated degradation of haem is
restricted to the microsomes and is not detectable in
nuclei (Fig. 1). Marver (1969) has shown that exo-
genously administered haematin is localized mainly
in microsomal fractions and is not detectable in
purified nuclear preparations. We have not been able
to detect any radioactivity in purified nuclear prepara-
tions when the animals are injected with [2-14C]-
allylisopropylacetamide. Significant amounts are
localized only in the cytosol and microsomal frac-
tions. Exogenous administration of haematin has, no
effect on the distribution pattern of radioactivity
(Satyanarayana Rao & Padmanaban, 1973). Al-
though these results do not eliminate the possibility
that a minute quantity of exogenously administered
haematin or allylisopropylacetamide is localized in
the nuclei, the bulk of the evidence indicates that the
primary events leading to the repression of the en-
zyme by the exogenous administration of haematin,
as well as the de-repression of the enzyme by the
degradation ofendogenous haem, are not likely to be
taking place in the nuclei.
The fact that the cortisol-mediated induction of
8-aminolaevulinate synthetase by allylisopropyl-
acetamide is sensitive to actinomycin D indicates
that the hormone metabolite may act at the trans-
criptional level. The results proving the efficiency of
haematin to block cortisol-mediated induction of the
enzyme when given at zero time or 4h after the
hormone administration (Fig. 2) also substantiate
the contention that the hormone metabolite and
haematin act at transcriptional and translational
sites respectively. Even though there is a marginal
increase in the cytosolic enzyme activity when
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haematin is administered 4h after enzyme induction,
the fact that this is a transient phenomenon indicates
that it is only a question of time before the effect of
haematin is felt at this step. Irrespective of the mecha-
nisms proposed to explain the differential effect of
haematin in vivo on pre-induced mitochondrial and
cytosolic 8-aminolaevulinate synthetase activities
(Hayashi et al., 1972; Gayathri et al., 1973), the
results are not against a translational site of action for
haematin and a transcriptional site for the hormone
metabolite.
Finally, the implicated site of action of allyliso-
propylacetamide has to be reconciled with the finding
that 8-aminolaevulinate synthetase induction owing
to the drug in the intact animal is sensitive to actino-
mycin D (Marver et al., 1966). We therefore propose
that a limited amount ofmRNA exists for the enzyme
in normal liver. Soon after allylisopropylacetamide
administration the translation of this mRNA pro-
vides a trigger for transcription and formation of
more mRNA. These observations are, however, not
compatible with the results obtained in the chick
embryo liver culture system where the RNA for
the enzyme appears to accumulate in presence of
allylisopropylacetamide and cycloheximide (Sassa &
Granick, 1970; Tyrrell & Marks, 1972). More direct
experiments on the synthesis of mRNA for the
enzyme only may resolve this problem.
Translational regulation of 8-aminolaevulinate syn-
thetase messenger by positive control
The absence of cytochrome P-450 degradation in
phenobarbital-mediated induction of 8-aminolaevu-
linate synthetase is not compatible with the micro-
somal haem being the 'co-repressor' for the enzyme
at the translational level. Previously we have shown
that in fed female rats phenobarbital is a weak in-
ducer of the enzyme compared with allylisopropyl-
acetamide and the increase in enzyme activity is
detectable only after two injections of the drug at 12h
intervals. Under these conditions phenobarbital
decreased the rate of enzyme degradation in vivo
(Satyanarayana Rao et al., 1972). It is clear, however,
that this explanation is not feasible in the case of
starved male rats where a single injection of pheno-
barbital induces 8-aminolaevulinate synthetase to a
moderate extent within 6-8h, the induction process
being sensitive to actinomycin D (Fig. 3). We propose
that a drug such as phenobarbital primarily increases
the rate of apo-cytochrome P.450 synthesis, which in
turn promotes the translation of 8-aminolaevulinate
synthetase messenger, leading to more enzyme
formation and haem synthesis. This would result in
subsequent increases in cytochrome P450 content.
Thus, an alternative possible mode of haem action
would be to annul the positive control exerted by the
apo-protein on the translation of the enzyme.
The mode of action of phenobarbital suggested
here requires rethinking of the idea that drugs pri-
marily induce 8-aminolaevulinate synthetase, which
causes increased haem synthesis, and the haem in
turn causes increased cytochrome P-450 synthesis
(Granick, 1966; Marver, 1969; Baron & Tephly,
1969a,b, 1970). We have discussed (Satyanarayana
Rao & Padmanaban, 1973) recent studies which
indicate that the availability of haem is not rate-
limiting for cytochromeP-450 synthesis, at least under
certain conditions. In these cases the increase in
cytochrome P-450 content owing to phenobarbital
administration is thus necessarily due to a direct
effect of the drug on the rate of apo-protein synthesis,
since Greim et al. (1970) have shown that pheno-
barbital does not affect the rate of cytochrome P450
degradation. Availability ofhaem could become rate-
limiting ifthe rate ofapo-protein synthesis is consider-
ably enhanced, which may occur in the starved male
rat. We propose that the extra haem is made available
by the promotion of 8-aminolaevulinate synthetase
synthesis by the apo-protein at the translational level.
It is believed that more than one species or form of
cytochrome P-450 could exist in liver microsomes
(Mannering et al., 1969; Atkin et al., 1972). As such
the apo-cytochrome P-450 involved in 8-amino-
laevulinate synthetase induction could be one of the
several species or it could even be the apo-protein of
a minor haemoprotein component that undergoes a
metabolic fate similar to that of cytochrome P450.
De Matteis & Gibbs (1972) have proposed an alter-
native explanation for the inductive effects of 3,5-
diethoxycarbonyl-1,4-dihydrocollidine and phenyl-
butazone,whichresembleallylisopropylacetamideand
phenobarbital respectively in their effects on 8-amino-
laevulinate synthetase and cytochromeP-450. 3,5-Di-
ethoxycarbonyl-1,4-dihydrocollidine is an inhibitor
of haem synthesis and also decreases cytochrome
P-450 content initially. Thus 8-aminolaevulinate
synthetase could be induced as a result of the lack of
haem to 'repress' it. In the case of phenylbutazone
De Matteis & Gibbs (1972) proposed that it could
either fix haem as cytochrome P-450, thus rendering
it unavailable for repression, or the effects of the drug
could be due to its general effects on liver protein
metabolism. For allylisopropylacetamide, there is no
inhibition ofhaem synthesis and the effect is primarily
one of cytochrome P450 haem degradation, suggest-
ing that this haem is normally available for repression.
To propose that, for phenobarbital, haem might be
fixed as cytochrome P-450 would appear inconsistent
with the assumption made to explain the effects of
allylisopropylacetamide. However, this situation is
not inconceivable, because of the possible existence
of several species or forms of closely related haemo-
proteins in liver microsomes (Mannering et al., 1969;
Atkin et al., 1972). Thus, whereas oneform is suscept-
ible to degradation by allylisopropylacetamide, drugs
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Table 4. [s9Fe]Ferric citrate incorporation into microsomalhaem under conditions ofrepression of8-aminolaevulinate
synthetase by endogenous haem
Adult female rats (100-1 lOg) were starved for 48h, which included the duration ofthe experiment. Allylisopropyl-
acetamide was injected subcutaneously at a concentration of 300mg/kg. [59Fe]Ferric citrate (5,uCi/animal) was
injected intraperitoneally immediately after allylisopropylacetamide. The animals were killed after 4h and the
radioactivity incorporated into microsomal haem and the cytochromeP450 content were measured as described
in the Experimental section. 8-Aminolaevulinate synthetase activity was assayed in the liver homogenate. The
results represent the averages of two experiments where two livers were pooled in each experiment.
Treatment
Saline control
Allylisopropylacetamide
Aminolaevulinic acid
Allylisopropylacetamide
+aminolaevulinic acid
8-Aminolaevulinate
synthetase activity
(nmol ofaminolaevulinate/g
of liver)
16.8
171.5
17.5
102.3
Cytochrome P-450
content
(nmol/mg of
microsomal
protein) (A)
0.75
0.55
0.70
0.49
Microsomal haem
radioactivity
(c.p.m./mg of
microsomal protein)
(B)
296
228
326
301
such as phenobarbital and phenylbutazone might
bind haem in the form of a species of cytochrome
P-450, or closely related haemoproteins with slow
turnover rates, consequently rendering haem unavail-
able for repression. Ours is an alternative model,
which in addition to the ones already mentioned can
also explain other relevant observations as follows.
(1) The inductive effect of allyisopropylacetamide
can be explained on the basis that it causes haem
degradation, making the apo-protein available to
promote translation of 8-aminolaevulinate synthetase
messenger.
(2) When haematin is given with allylisopropyl-
acetamide, it may bind to the apo-protein (regulator)
and thus prevent 8-aminolaevulinate synthetase
induction. However, it is known that haematin does
not counteract the decrease in cytochrome P450
contents owing to allylisopropylacetamide admini-
stration (Sweeney et al., 1972; Satyanarayana Rao &
Padmanaban, 1973). It is still possible that haem could
combine with the apo-protein, but the newly formed
haemoprotein may not show the spectral properties of
cytochrome P450. It is also possible that the regu-
lator of 8-aminolaevulinate synthetase is not cyto-
chrome P450, but a closely associated haemoprotein
undergoing a similar metabolic fate. We have investi-
gated whether there is evidence for the formation of a
microsomal haemoprotein under conditions when
the induction of 8-aminolaevulinate synthetase is
blocked by haem. Since exogenously administered
haematin can bind non-specifically to different pro-
teins, we have looked for protein-bound microsomal
haem when the induction of 8-aminolaevulinate
synthetase by allylisopropylacetamide is blocked by
Vol. 134
haem synthesized endogenously from 8-aminolaevu-
linate (Song et al., 1971). The results in Table 4 show
that under conditions ofenzyme repression by amino.
laevulinate a significant amount of 5"Fe-labelled
protein-bound haem is present in the microsomes.
The higher ratio of microsomal haem radioactivity
to the cytochrome P-450 content under repressed
conditions as compared with induced conditions
indicates that at least part of the haem synthesized
from aminolaevulinate is bound to microsomal pro-
tein in a form that is not susceptible to allylisopropyl-
acetamide-mediated degradation.
(3) Pretreatment of rats with phenobarbital de-
creases the inductive effect ofallylisopropylacetamide
(Satyanarayana Rao & Padmanaban, 1971). This
could be because of the unavailability of the active
hormone metabolite owing to increased metabolism.
However, when phenobarbital and allylisopropyl-
acetamide are administered together a striking induc-
tion of 8-aminolaevulinate synthetase is observed as
compared with that observed with allylisopropyl-
acetamide only (Table 5). These results can be ex-
plained on the basis that under these conditions the
net amount of apo-cytochrome P-450 would be high
because phenobarbital would accelerate apo-cyto-
chrome P-450 synthesis, whereas allylisopropyl-
acetamide would degrade the haem moiety. Pretreat-
ment with phenobarbital increases cytochrome P450
content as a result primarily of an increase in the rate
of apo-protein synthesis followed by an increase in
the rate of haem synthesis. This causes an increase in
the activity of drug-metabolizing enzymes, for which
the endogenous steroids appear to be the natural
substrates. The increased metabolism of the steroids
Ratio of
B/A
395
414
466
614
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Table 5. Effect ofphenobarbital on 8-aminolaevulinate synthetase induction by allylisopropylacetamide
Fed female rats (100-llOg) were given simultaneous injections of phenobarbital (80mg/kg) and allylisopropyl-
acetamide (400mg/kg) or allylisopropylacetamide after phenobarbital pretreatment. Phenobarbital pretreatment
involved three injections of the drug at 24h intervals. The animals were killed 6h after allylisopropylacetamide
injection and 8-aminolaevulinate synthetase activity was assayed in liver homogenate. The results represent the
averages of two experiments in which two livers were pooled in each experiment.
Aminolaevulinate synthetase activity
Treatment (nmol of aminolaevulinate/g of liver)
Normal 18.1
Phenobarbital (one injection) 20.2
Phenobarbital (three injections) 49.3
Allylisopropylacetamide (one injection) 89.3
Allylisopropylacetamide+phenobarbital (one injection) 140.9
Phenobarbital pretreated+allylisopropylacetamide 59.3
(one injection)
would possibly deplete the pool of active steroid
metabolite involved in the induction of 8-amino-
laevulinate synthetase. This situation is the same as
that for repeated administration of allylisopropyl-
acetamide. However, a single simultaneous admini-
stration ofphenobarbital and allylisopropylacetamide
elicits a striking induction of the enzyme and pre-
sumably the active hormone metabolite is available
endogenously under these conditions.
In summary, we propose that the apo-protein of a
microsomal haemoprotein, which could be a species
of apo-cytochrome P-450 or a closely associated
protein undergoing a similar metabolic fate, facili-
tates induction of 8-aminolaevulinate synthetase at
the translational level. Haem binding to this apo-
protein abolishes this positive control. The transla-
tion of 8-aminolaevulinate synthetase mRNA pro-
vides a trigger for transcription and formation of
more mRNA. A hormone metabolite is required for
the transcription.
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